ID   16D3-C1
AC   CVCL_XH56
DR   Wikidata; Q93299903
RX   Patent=US9127065;
RX   PubMed=23479511;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-4486.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P21860; Human ERBB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 02-05-24; Version: 5
//
RX   Patent=US9127065;
RA   Chardes T., Pelegrin A., Larbouret C., Gaborit N., Lazrek Y.;
RT   "Anti-human HER3 antibodies and uses thereof.";
RL   Patent number US9127065, 08-Sep-2015.
//
RX   PubMed=23479511; DOI=10.1593/neo.121960;
RA   Lazrek Y., Dubreuil O., Garambois V., Gaborit N., Larbouret C.,
RA   Le Clorennec C., Thomas G., Leconet W., Jarlier M., Pugniere M.,
RA   Vie N., Robert B., Monnet C., Bouayadi K., Kharrat H., Mondon P.,
RA   Pelegrin A., Chardes T.;
RT   "Anti-HER3 domain 1 and 3 antibodies reduce tumor growth by hindering
RT   HER2/HER3 dimerization and AKT-induced MDM2, XIAP, and FoxO1
RT   phosphorylation.";
RL   Neoplasia 15:335-347(2013).
//